Researchers developed the Splicing Neo Antigen Finder (SNAF) workflow, integrating deep learning to identify shared immunogenic neoantigens in cancers, offering new targets for cancer immunotherapy, particularly in melanoma and ovarian cancer.
StoryCatch Partners Acquires EmpiraMed
What You Should Know: – StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that